GIUDICE, VALENTINA
 Distribuzione geografica
Continente #
AS - Asia 9.991
NA - Nord America 4.651
EU - Europa 2.658
SA - Sud America 578
AF - Africa 89
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 9
Totale 17.986
Nazione #
HK - Hong Kong 7.318
US - Stati Uniti d'America 4.569
SG - Singapore 1.429
IT - Italia 662
CN - Cina 549
DE - Germania 527
BR - Brasile 485
RU - Federazione Russa 441
VN - Vietnam 281
FI - Finlandia 244
ES - Italia 182
IE - Irlanda 124
UA - Ucraina 118
GB - Regno Unito 94
IN - India 89
KR - Corea 83
TR - Turchia 76
SE - Svezia 64
AT - Austria 55
AR - Argentina 42
CA - Canada 42
CZ - Repubblica Ceca 39
JP - Giappone 38
PL - Polonia 30
NL - Olanda 29
ZA - Sudafrica 27
BD - Bangladesh 26
MX - Messico 26
ET - Etiopia 23
ID - Indonesia 23
EC - Ecuador 19
EG - Egitto 14
PK - Pakistan 11
FR - Francia 10
PY - Paraguay 9
AE - Emirati Arabi Uniti 8
EU - Europa 8
VE - Venezuela 8
NP - Nepal 7
UZ - Uzbekistan 7
AU - Australia 6
JO - Giordania 6
LT - Lituania 6
CO - Colombia 5
IQ - Iraq 5
KE - Kenya 5
TH - Thailandia 5
DZ - Algeria 4
MA - Marocco 4
MK - Macedonia 4
NZ - Nuova Zelanda 4
PE - Perù 4
AZ - Azerbaigian 3
GR - Grecia 3
HN - Honduras 3
HR - Croazia 3
IR - Iran 3
KG - Kirghizistan 3
LU - Lussemburgo 3
MY - Malesia 3
PH - Filippine 3
PT - Portogallo 3
BE - Belgio 2
BJ - Benin 2
CH - Svizzera 2
CL - Cile 2
GE - Georgia 2
HU - Ungheria 2
IL - Israele 2
JM - Giamaica 2
KZ - Kazakistan 2
LC - Santa Lucia 2
LY - Libia 2
MD - Moldavia 2
OM - Oman 2
SA - Arabia Saudita 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CM - Camerun 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DJ - Gibuti 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GD - Grenada 1
GN - Guinea 1
GT - Guatemala 1
IS - Islanda 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
Totale 17.978
Città #
Hong Kong 7.307
Singapore 615
Dallas 582
Ann Arbor 465
Chandler 453
Ashburn 406
Munich 390
Woodbridge 326
Princeton 305
Wilmington 188
Houston 167
Valencia 156
Jacksonville 148
Helsinki 144
Beijing 134
Naples 132
Dong Ket 112
Dublin 108
Los Angeles 93
Moscow 89
New York 70
Nuremberg 66
Salerno 63
Ho Chi Minh City 60
São Paulo 60
Andover 57
Izmir 57
Rome 46
Boardman 43
Turku 43
Hanoi 37
Brno 36
Redwood City 35
Nanjing 34
Washington 33
Santa Clara 32
Brooklyn 31
Stockholm 27
Warsaw 27
Fisciano 24
Rio de Janeiro 24
Tokyo 24
Addis Ababa 23
Orem 23
Pellezzano 23
Pune 23
Chennai 22
Milan 22
Vienna 22
Johannesburg 21
Seattle 21
Denver 20
Atlanta 19
Düsseldorf 18
Fairfield 18
Phoenix 18
Changsha 17
Jyväskylä 17
London 17
Manchester 17
The Dalles 17
Amsterdam 16
Columbus 16
Montreal 15
Belo Horizonte 14
Council Bluffs 14
Norwalk 14
Poplar 14
Seoul 14
Boston 13
Brasília 13
Toronto 13
Lappeenranta 12
Nanchang 12
Tianjin 12
Curitiba 11
Guangzhou 11
West Jordan 11
Chicago 10
Quito 10
San Francisco 10
Shanghai 10
Ankara 9
Mexico City 9
Cambridge 8
Cava de' Tirreni 8
Charlotte 8
Domicella 8
Mumbai 8
Shenyang 8
Buffalo 7
Caserta 7
Catania 7
Da Nang 7
Dhaka 7
Frankfurt am Main 7
Haiphong 7
Jakarta 7
Juiz de Fora 7
Kathmandu 7
Totale 14.028
Nome #
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study 872
Mucosal-Associated Invariant T Cells in T-Cell Non-Hodgkin Lymphomas: A Case Series 690
Low-Density Granulocytes Are Decreased in Acute Myeloid Leukemia and in Myelodysplastic Syndromes with Negative Prognostic Factors 628
Hemopoiesis and Immune Cell Perturbations during Venetoclax Plus Azacytidine Treatment in Acute Myeloid Leukemia 461
DECREASED LOW-DENSITY GRANULOCYTES AS POSSIBLE DIAGNOSTIC MARKERS OF MYELODYSPLASTIC SYNDROMES WITH EXCESS OF BLASTS 457
Aplastic anemia: Pathophysiology 453
Suitability of Different Cytological Preparations for Molecular Analysis of Advanced Non-Small Cell Lung Cancers 449
Hodgkin Lymphoma and Hairy Cell Leukemia Arising from Chronic Lymphocytic Leukemia: Case Reports and Literature Review 392
Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma 336
Chondrogenic Commitment of human Bone Marrow Mesenchymal Stem Cells in a perfused, hTGF-β1-releasing PLGA microcarrier seeded, collagen hydrogel 332
Immature forms of low density granulocytes are increased in acute myeloid leukemia and myelodysplastic syndromes 321
Cell-free regenerative medicine: identifying the best source of mesenchymal stem cells for skin therapy in Systemic Sclerosis 307
A Rare Immune-Related Mesenteric and retroperitoneal serositis in a Multi-Refractory Hodgkin Lymphoma Patient Successfully Treated with Chylolymphostatic Surgery 301
WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes 298
High-Risk Genetic Multiple Myeloma: From Molecular Classification to Innovative Treatment with Monoclonal Antibodies and T-Cell Redirecting Therapies 274
Involvement of soluble forms of receptor of the urokinase-type plasminogen activator (UPAR) in hematopoietic stem cell homing 274
All Roads Lead to Interferon-γ: From Known to Untraveled Pathways in Acquired Aplastic Anemia 267
Effects of selected preanalytical variables on Dried Blood Spot (DBS) and Volumetric Adsorptive Microsampling (VAMS) based bioanalytical methods for the determination of four β-lactam antibiotics 220
Clinical efficacy of azacytidine and venetoclax and prognostic impact of Tim-3 and galectin-9 in acute myeloid leukemia and high-risk myelodysplastic syndromes: A single-center real-life experience 208
Contribution of peripheral blood mononuclear cells isolated by advanced filtration system to myogenesis of human bone marrow mesenchymal stem cells co-cultured with myoblasts 197
Aptamer-based proteomics of serum and plasma in acquired aplastic anemia 196
Giant plasma cells with multiple immature nuclei in a young woman with newly diagnosed multiple myeloma 196
Gender Differences in the Impact of COVID-19 Pandemic on Mental Health of Italian Academic Workers 195
Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab-based regimens 173
Eltrombopag Improves Hematopoiesis in Patients with Low to Intermediate-2 Risk Myelodysplastic Syndrome (MDS). 173
Autologous And Allogeneic Stem Cell Transplantation Is Associated With Long-Lasting Endocrine Disorders 168
Bone marrow mesenchymal stem cells as a possible ruxolitinib reservoir in the bone marrow niche 160
Accelerated and persistent bone loss after autologous and allogeneic stem cell transplantation 157
Anaplastic CD30+ alk- (micro) lymphoma arising out of mediastinal Plasma Cell Castleman’s disease in immunocompetent patient treated by rituximab- dexametasone and continuous lenalidomide 150
High incidence of cytomegalovirus reactivation in patients with lymphoma treated with bendamustine 148
Circulating T Regulatory Cells Are Persistently Reduced in Non-Severe Acquired Aplastic Anemia 146
3D Biomimetic Scaffold for Growth Factor Controlled Delivery: An in-vitro study of Tenogenic events on Wharton’s Jelly Mesenchymal stem cells 146
Lenalidomide-Mediated NK Cells Expansion In Elderly Multiple Myeloma Patients 144
The Role of B Regulatory Cells in the Immunological Escape of Tumor Cells in Hodgkin Lymphoma 142
67 KDA laminin receptor (67LR) in normal and neoplastic hematopoietic cells: is its targeting a feasible approach? 141
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation increases the number of circulating natural killer cells 137
Prolonged low-dose lenalidomide treatment increases the number of circulating natural killer cells in multiple mieloma patients 132
3D in-vitro cultures of human bone marrow and Wharton’s jelly derived mesenchymal stromal cells show high chondrogenic potential 131
Prolonged azacitidine treatment in the management of elderly patients with high risk myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia not eligible for standard intensive therapy 131
Prophylactic therapy with oral low-dose valgancyclovir in cytomegalovirus-positive allogeneic stem cell transplant recipients 130
Efficacy and safety of splenectomy in adult autoimmune hemolytic anemia. 121
Induction therapy with continuous alternate-day low dose lenalidomide combined with low-dose prednisone in octogenarian Multiple Myeloma patients 115
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation 111
Cytomegalovirus reactivation prophylaxis with low dose valgancyclovir after hematopoietic stem cell transplantation 111
Sirt-1 as a novel therapeutic target for improving nitric oxide release in heterozygous and homozygous patients for mthfr mutations 111
In vitro apoptotic effects of farnesyltransferase blockade in acute myeloid leukemia cells. 111
Daily low-dose valgancyclovir is safe and effective CMV-reactivation prophylaxis in HLA-identical sibling hematopoietic stem cell transplantation. Bone Marrow Transplantation 110
Urokinase type plasminogen activator receptor (UPAR) as a new therapeutic target in cancer. 110
Electrophysiological Studies in Combination With Interim-Positron Emission Tomography Scan for Prevention of Severe Brentuximab-Vedotin-Induced Neurotoxicity 109
Reproductive issues in patients undergoing Hematopoietic Stem Cell Transplantation: an update 107
Pre- and Post-COVID-19 Antibiotic Consumption and Stewardship Program in a Southern Italian Hospital 103
Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment. 102
Role of Laparoscopic Splenectomy in Elderly Immune Thrombocytopenia. 102
A simple flow cytometric score based on CD49d and homing marker expression in chronic lymphocytic leukemia (CLL). 102
Flow Cytometric Detection Of B-cell Membrane Markers CD5, CD11c, CD20, CD38 And CD49d May Predict Outcome In Chronic Lymphocytic Leukemia And Non-Hodgkin Lymphoma 100
Safety of Adjuvanted Recombinant Herpes Zoster Virus Vaccination in Fragile Populations: An Observational Real-Life Study 99
Endocrine disorders after autologous and allogeneic stem cell transplantation 98
Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases 97
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency 94
Therapeutic drug monitoring might identify poor responders to ruxolitinib treatment in myeloproliferative neoplasms 94
Stem Cells from Healthy and Tendinopathic Human Tendons: Morphology, Collagen and Cytokines Expression and Their Response to T3 Thyroid Hormone 93
Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. 92
BONE MARROW MESENCHYMAL STEM CELLS AS FACILITATOR OF RUXOLITINIB-MEDIATED INHIBITION OF JAK2 MUTADED CELLS 92
Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens 91
Stem cell and macrophage roles in skeletal muscle regenerative medicine 89
Combined liposomal amphotericin b and surgery as successful management for pulmunary mucormycosis in a patient with acute myeloid leukemia 87
BRAF V600E mutation associated with papillary high-grade serous ovarian cystadenocarcinoma in a 22q11.2DS patient 85
Advanced biopolymer filtration system for Peripheral Blood Mononuclear Cells collection: a study on filter composition and in vitro filtrate composition 84
Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic hematopoietic stem cell transplantation 83
Bone Marrow Failure Syndromes, Overlapping Diseases with a Common Cytokine Signature 81
How to Improve the Definition of Chronic Lymphocytic Leukemia Outcome Using a Simple Flow Cytometric Score Based on CD49d and Homing Marker Expression 78
Identification of uPAR Variants Acting as ceRNAs in Leukaemia Cells 78
Peripheral blood mononuclear cells contribute to myogenesis in a 3D bioengineered system of bone marrow mesenchymal stem cells and myoblasts 76
Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic haematopoietic stem cell transplantation. 76
Myogenic commitment of human stem cells by myoblasts Co-culture: a static vs. a dynamic approach 76
Axitinib in Ponatinib-Resistant B-Cell Acute Lymphoblastic Leukemia Harboring a T315L Mutation 75
Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters 73
OPSI threat in hematological patients 73
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 71
Sex, Age, and Previous Herpes Zoster Infection Role on Adverse Events Following Immunization with Adjuvanted Recombinant Vaccine 70
Real-world experience with the Sydney System on 1458 cases of lymph node fine needle aspiration cytology 69
Daily low-dose valgancyclovir is safe and effective CMV-reactivation prophylaxis in HLA-identical sibling hematopoietic stem cell transplantation 67
A case series of blastic plasmacytoid dendritic cell neoplasia 67
Can we turn off the “Covid-biting-tail” inflammation? 67
Prophylactic letermovir decreases cytomegalovirus reactivation after stem cell transplantation: a single-center real-world evidence study 67
Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies 64
A Frail Hairy Cell Leukemia Patient Successfully Treated with Pegylated Interferon-α-2A 64
Biomimetic proteolipid vesicles for reverting GPI deficiency in paroxysmal nocturnal hemoglobinuria 64
Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma 64
Sicurezza del vaccino ricombinante anti-herpes Zoster virus in popolazioni fragili: uno studio osservzionale 63
Successful management of pulmonary mucormycosis with liposomal amphotericin B and surgery treatment: a case report 62
Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson's Disease 61
Pharmacovigilance of Selective Serotonin Reuptake Inhibitors and Gender Differences in Stroke Incidence 61
Clinical Utility of TRBC1 Addition in Multiparametric Flow Cytometry for T Cell Lymphoma Diagnosis 61
c-Kit M541L variant is related to ineffective hemopoiesis predisposing to clonal evolution in 3D in vitro biomimetic co-culture model of bone marrow niche 59
Implementation of International Prognostic Index with flow cytometry immunophenotyping for better risk stratification of chronic lymphocytic leukemia 59
Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience 57
COVID-19 vaccine-associated lymphadenopathy: a review 56
CD38 prognostic role in chronic lymphocytic leukemia patients treated with standard chemotherapy or targeted agents: a monocentric real-life experience 56
Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B 55
Totale 15.806
Categoria #
all - tutte 56.601
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.601


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021345 0 0 0 0 0 28 42 11 29 39 58 138
2021/2022569 14 2 14 43 16 15 4 17 72 46 75 251
2022/20231.182 94 108 85 129 111 209 54 122 155 4 58 53
2023/2024921 77 90 73 59 71 162 71 71 17 40 53 137
2024/20252.716 76 36 42 84 173 277 662 249 447 122 253 295
2025/202610.775 1.420 3.933 3.465 739 1.158 60 0 0 0 0 0 0
Totale 18.276